BPA Call HT001420A0025-HT001420F0249
Award Date
9/30/20
Potential Completion Date
9/29/21
Potential Value
$45K
Federal Agency
Defense Health Agency
Awardee
Ark Diagnostics, Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Fremont, CA 94538, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price Blanket Purchase Agreement (BPA) call order awarded by the Bureau of Medicine and Surgery, a Defense agency, to Ark Diagnostics, Inc. The BPA has a ceiling value of $18,015 and was awarded on December 12, 2014 with a period of performance through December 18, 2014. The award is for the delivery of ARK Diagnostics List products, which includes reagents, assay kits, and other consumable laboratory supplies used for managing drug levels. Ark Diagnostics is a for-profit...
This is a firm fixed price contract awarded by the Defense Health Agency (DHA) to Ark Diagnostics, Inc., a privately held manufacturer of in vitro diagnostic immunoassays. The $20,000 contract is for the delivery of reagents to support laboratory testing. The contract is a Blanket Purchase Agreement (BPA) call order, enabling DHA to place fixed price orders for Ark's products on an as-needed basis. Ark has previously received other BPA call orders from DHA and other Department of Defense...
This is a firm fixed price Blanket Purchase Agreement (BPA) call order awarded by the Defense Health Agency (DHA) to Ark Diagnostics, Inc. for the delivery of reagents and peripheral consumables. The BPA has a ceiling value of $20,000.00 and was awarded on October 6, 2015 with an ultimate completion date of October 5, 2016. Under this BPA, Ark Diagnostics has received two call orders valued at $45,000 each - one to deliver methotrexate reagents and kits, and another to provide reagent...
This is a firm fixed price purchase order awarded to Ark Diagnostics, Inc. by the U.S. Army Medical Command (MEDCOM) to provide reagents and methotrexate assay kits over a five-year period from October 2023 through September 2028. The award has a total ceiling value of $338,385.54. Ark Diagnostics, Inc. is a privately held company that develops and commercializes in vitro diagnostic immunoassays. This contract was not set aside for any specific business type. Ark Diagnostics has previously...
This firm fixed price purchase order for $706,192 was awarded by the Department of the Army Medical Command to Ark Diagnostics, Inc. to supply methotrexate assay kits. The award supports the requirements outlined in the pre-solicitation notice seeking FDA-approved reagents, supplies, calibrators, controls and materials compatible with Roche analyzers at Brooke Army Medical Center and surrounding clinics. Ark Diagnostics will deliver the methotrexate assay kits under the $8 million blanket...
The Department of the Army Medical Command awarded a firm fixed price purchase order contract to Ark Diagnostics, Inc., a privately held foreign-owned manufacturer, to provide methotrexate assay kits. The $134,700.00 contract has a completion date of December 14, 2018 and was set aside for small businesses. Ark Diagnostics has supplied similar pharmaceutical testing products, including fentanyl assay kits and anesthesia apparatuses, to Department of Defense health agencies under past contract...
This firm fixed price blanket purchase agreement (BPA) call contract was awarded by the Defense Health Agency to Polyscientific Research and Development Corp. to provide reagents and supplies for the agency's Pathology Department. The contract has a potential value of $32,115.85 and requires delivery of the requested products and services by November 10, 2020. Performance will occur in Bethesda, Maryland. No set-aside provision was used for this award to support the Defense Health Agency's...
This federal contract award, valued at $75,000.00, was issued by the Defense Health Agency (DHA) to Archerdx LLC, a subsidiary of Invitae Corporation. The contract is for the provision of lab supplies and assays, medical, surgical instruments, equipment, and supplies. The contract type is a Blanket Purchase Agreement (BPA) call order, with a firm fixed price pricing structure. The award is not associated with a set-aside program. Archerdx LLC has previously received federal contract awards...
This federal contract award is for the provision of REAGENTS AND SUPPLIES to the Defense Health Agency. The contract, which is a Blanket Purchase Agreement (BPA) call, was awarded to Cancer Diagnostics, Inc. (CDI), a for-profit manufacturer of goods for the anatomic pathology and histology market. The award has a firm fixed price pricing type and does not have a set-aside designation. The potential value of the contract is $150,000.00, and the period of performance runs from the award date of...
This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the Federal Acquisition Service (FAS) to Ortho-Clinical Diagnostics, Inc., a for-profit manufacturer of medical equipment and diagnostic solutions. The contract is valued at $170,418.75 and includes the provision of medical items, reagents, and consumables for the USNS Mercy hospital ship. The award is not associated with a set-aside designation. Ortho-Clinical Diagnostics holds several indefinite-delivery vehicles...